A Late COVID-19 Complication: Male Sexual Dysfunction.

Area of Science:

• Urology
• Infectious Diseases
• Sexual Medicine

Background:

• The COVID-19 pandemic has generated extensive research on its systemic effects.
• While COVID-19 causes systemic inflammation affecting multiple organs, its impact on the urogenital system remains under-documented.
• Understanding the full spectrum of COVID-19's impact is crucial for comprehensive patient care.

Observation:

• This case report details two male patients who developed anorgasmia post-COVID-19 recovery.
• Both patients had no other identifiable risk factors for sexual dysfunction.
• No viral replication or inflammation was detected in the urogenital organs of the affected individuals.

Findings:

• The primary finding is the occurrence of anorgasmia in two male patients following SARS-CoV-2 infection.
• The absence of other etiological factors strongly implicates COVID-19 as a contributing cause.
• This suggests a potential neurological or indirect inflammatory mechanism affecting sexual function.

Implications:

• COVID-19 may contribute to sexual dysfunction, specifically anorgasmia, in male patients.
• Further research is needed to elucidate the precise mechanisms linking SARS-CoV-2 to sexual dysfunction.
• Clinicians should consider sexual health when managing patients recovering from COVID-19, particularly those with persistent symptoms.